REATA PHARMACEUTICALS INC 4
4 · REATA PHARMACEUTICALS INC · Filed Jan 6, 2017
Insider Transaction Report
Form 4
Bass James Edward
Director
Transactions
- Conversion
Class A common stock
2017-01-05+38,447→ 41,902 total(indirect: By Trust) - Conversion
Class B common stock
2017-01-05−38,447→ 0 total(indirect: By Trust)→ Class A common stock - Conversion
Class B common stock
2017-01-05−28,762→ 0 total→ Class A common stock - Conversion
Class B common stock
2017-01-05−16,107→ 0 total(indirect: By Trust)→ Class A common stock - Conversion
Class A common stock
2017-01-05+28,762→ 59,347 total - Conversion
Class A common stock
2017-01-05+16,107→ 17,555 total(indirect: By Trust)
Footnotes (1)
- [F1]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time.